Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial
van Vollenhoven, RF, Dr, Ernestam, S, MD, Geborek, P, MD, Petersson, IF, MD, Cöster, L, MD, Waltbrand, E, MD, Zickert, A, MD, Theander, J, MD, Thörner, Å, MD, Hellström, H, MD, Teleman, A, MD, Dackhammar, C, MD, Akre, F, MD, Forslind, K, MD, Ljung, L, MD, Oding, R, MD, Chatzidionysiou, A, MD, Wörnert, M, RN, Bratt, J, MD
Published in The Lancet (British edition) (2009)
Published in The Lancet (British edition) (2009)
Get full text
Journal Article